(12 December 2025 – Hong Kong) Gleneagles Hong Kong (Gleneagles) will become the first healthcare network in the city to offer an integrated service which analyses genomic, epigenetic and clinical health data using the AI-powered platform, Longevity.Omics, developed by Quantum Life. This milestone initiative kick-starts Gleneagles’ longevity programme, reinforcing its commitment to delivering preventive and personalised healthcare.

Against the backdrop of Hong Kong’s rapidly ageing population, public interest in healthy ageing and precision medicine has been on the rise. To meet the changing expectation and increasing healthcare needs of patients, Gleneagles has been striving to introduce advanced technologies to enhance patient journey from consultation, diagnostics to treatments. Leveraging Quantum Life’s proprietary AI-driven platform, Gleneagles will be able to integrate Whole Genome Sequencing (WGS), epigenetic assessment, and patient’s clinical data into a comprehensive analysis to achieve lifecycle healthy longevity management. This new service will be available from the first quarter of 2026 at Gleneagles Medical Clinic Central, Hong Kong, and Gleneagles Healthcare Wong Chuk Hang, as well as through Gleneagles TeleCare virtual consultation and remote care service. Gleneagles also plans to expand the service to other clinics and centres within its integrated healthcare network as the service develops.

Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia and Chief Executive Officer of Gleneagles Hospital Hong Kong, said, “At Gleneagles, we see innovation and technology as essential to shaping the future of healthcare. Over the years, we have been working with various healthtech partners to bring innovative solutions to our patients. This strategic collaboration with Quantum Life integrates AI and advanced multi-omics clinical analyses, which include genomics and epigenetics, into our services, enabling our patients to gain personalised health insights that support informed decisions and help prevent diseases before they develop. We believe this new service will set a new benchmark for personalised care.”

With the AI-powered platform, Longevity.Omics, only by a simple blood test can identify health risks and provide an organ-level epigenetic aging assessment, enabling early clinical intervention and better outcomes. A comprehensive report integrating patients’ clinical data obtained from health screening at Gleneagles, WGS data and epigenetic data will be generated. WGS data will be analysed to screen for hereditary diseases, cancer and common conditions, pharmacogenomics findings, longevity traits, and polygenic risk scores which can stratify the risk of common age-related diseases such as Alzheimer’s Disease and hypertension; while the epigenetic data which reveals and tracks patients' health, organ age and biological age as well as the effects of environment and emotions on physical aging will be provided. Designated doctors trained in interpreting these results will provide patients with personalised, preventive recommendations and follow-up referrals.

Quantum Life is a technology spin-off supported by the InnoHK Hong Kong Quantum AI Lab dedicated to revolutionising longevity and healthy aging. Christine Huang, Founder and CEO of Quantum Life, said, “Quantum Life is committed to transforming healthcare from ‘disease treatment’ to ‘aging intervention’. Gleneagles Hong Kong combines a strong academic foundation with advantages in international private healthcare services, focusing on medical innovation and technological breakthroughs to empower clinical diagnosis and treatment through technology—aligning closely with our development philosophy. As an AI-enabled precision healthcare enterprise, we leverage our proprietary Longevity.Omics platform to provide end-to-end solutions spanning multi-omics data analysis to clinicians' co-pilot, integrating next-generation sequencing technology to convert deep multi-omics data into clinically actionable reports. This helps Gleneagles establish an advanced longevity medicine framework and service system, delivering personalised precision health services and longevity solutions, and forming a complete ‘predictive diagnosis-intervention-follow-up’ closed loop. We are honored to partner with Gleneagles Hong Kong to drive cutting-edge technologies into clinical practice and inject momentum into the innovative development of healthy longevity.”

This partnership signals a new era of preventive healthcare in Hong Kong. By combining cutting-edge science with advanced AI technologies, Gleneagles and Quantum Life are paving the way for personalised strategies that help individuals stay healthier for longer.  More details about the service will be available on the websites of Gleneagles Medical Clinic Central, Hong Kong, and Gleneagles Healthcare in due course.